CADIAN CAPITAL MANAGEMENT, LP - GENMARK DIAGNOSTICS INC ownership

Quarter-by-quarter ownership
CADIAN CAPITAL MANAGEMENT, LP ownership history of GENMARK DIAGNOSTICS INC
ValueSharesWeighting
Q1 2020$14,375,000
-45.8%
3,489,055
-36.8%
0.71%
-39.7%
Q4 2019$26,540,000
-22.4%
5,517,767
-2.2%
1.17%
-27.9%
Q3 2019$34,197,000
-6.6%
5,643,118
+0.0%
1.63%
-1.5%
Q2 2019$36,608,000
+0.2%
5,640,748
+9.5%
1.65%
+15.9%
Q1 2019$36,528,000
+50.1%
5,152,009
+2.9%
1.42%
+25.8%
Q4 2018$24,339,000
-13.5%
5,008,122
+30.7%
1.13%
-11.4%
Q3 2018$28,153,000
-1.5%
3,830,399
-14.5%
1.28%
-7.0%
Q2 2018$28,580,000
+4.2%
4,479,615
-11.1%
1.38%
-7.2%
Q1 2018$27,424,000
+31.1%
5,041,133
+0.5%
1.48%
+16.2%
Q4 2017$20,923,000
-46.1%
5,017,483
+24.4%
1.28%
-29.8%
Q3 2017$38,833,000
-17.6%
4,032,483
+1.2%
1.82%
-20.9%
Q2 2017$47,147,000
+15.4%
3,985,360
+25.1%
2.30%
+17.5%
Q1 2017$40,849,000
+2.4%
3,186,382
-2.3%
1.96%
-8.0%
Q4 2016$39,907,000
-5.6%
3,260,378
-9.0%
2.12%
-4.8%
Q3 2016$42,265,000
+19.0%
3,581,747
-12.2%
2.23%
+14.3%
Q2 2016$35,503,000
+75.4%
4,080,759
+6.2%
1.95%
+43.6%
Q1 2016$20,241,000
-30.7%
3,840,759
+2.0%
1.36%
+29.4%
Q4 2015$29,218,000
+39.6%
3,765,159
+41.5%
1.05%
+39.3%
Q3 2015$20,936,000
+62.6%
2,660,195
+87.1%
0.75%
+98.9%
Q2 2015$12,878,000
+5.8%
1,421,462
+51.6%
0.38%
+15.5%
Q1 2015$12,169,000
-4.6%
937,5000.0%0.33%
+2.2%
Q4 2014$12,759,000
+60.3%
937,500
+5.6%
0.32%
+53.6%
Q3 2014$7,961,000
-33.7%
887,5000.0%0.21%
-41.5%
Q2 2014$12,008,000
+38.1%
887,500
+1.4%
0.36%
+64.5%
Q1 2014$8,698,000
-15.6%
875,000
+12.9%
0.22%
-18.1%
Q4 2013$10,300,000
+86.5%
775,000
+70.3%
0.26%
+63.6%
Q3 2013$5,524,000455,0000.16%
Other shareholders
GENMARK DIAGNOSTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Versor Investments LP 2,664,831$63,689,0003.80%
Chicago Capital Management, LLC 318,113$7,603,0003.54%
First Trust Capital Management L.P. 564,758$13,498,0002.64%
WATER ISLAND CAPITAL LLC 1,693,162$40,467,0002.47%
Sand Grove Capital Management LLP 992,068$23,710,0002.31%
EMC Capital Management 121,023$2,892,0002.06%
OMNI PARTNERS LLP 1,540,671$36,822,0001.82%
TIG Advisors, LLC 1,774,849$42,419,0001.60%
Cowen Prime Services LLC 174,850$4,179,0001.58%
G2 Investment Partners Management LLC 396,400$9,474,0001.50%
View complete list of GENMARK DIAGNOSTICS INC shareholders